RS58381B1 - Lečenje zavisnosti i poremećaja kontrole impulsa upotrebom pde7 inhibitora - Google Patents

Lečenje zavisnosti i poremećaja kontrole impulsa upotrebom pde7 inhibitora

Info

Publication number
RS58381B1
RS58381B1 RS20190228A RSP20190228A RS58381B1 RS 58381 B1 RS58381 B1 RS 58381B1 RS 20190228 A RS20190228 A RS 20190228A RS P20190228 A RSP20190228 A RS P20190228A RS 58381 B1 RS58381 B1 RS 58381B1
Authority
RS
Serbia
Prior art keywords
alkyl
pde7
substituted
group
addiction
Prior art date
Application number
RS20190228A
Other languages
English (en)
Serbian (sr)
Inventor
Gregory A Demopulos
George A Gaitanaris
Roberto Ciccocioppo
Original Assignee
Omeros Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/835,607 external-priority patent/US9220715B2/en
Application filed by Omeros Corp filed Critical Omeros Corp
Publication of RS58381B1 publication Critical patent/RS58381B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RS20190228A 2012-05-07 2013-05-07 Lečenje zavisnosti i poremećaja kontrole impulsa upotrebom pde7 inhibitora RS58381B1 (sr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261643611P 2012-05-07 2012-05-07
US13/835,607 US9220715B2 (en) 2010-11-08 2013-03-15 Treatment of addiction and impulse-control disorders using PDE7 inhibitors
PCT/US2013/039866 WO2013176877A2 (en) 2012-05-07 2013-05-07 Treatment of addiction and impulse-control disorders using pde7 inhibitors
EP13793319.8A EP2846805B1 (en) 2012-05-07 2013-05-07 Treatment of addiction and impulse-control disorders using pde7 inhibitors

Publications (1)

Publication Number Publication Date
RS58381B1 true RS58381B1 (sr) 2019-04-30

Family

ID=49624481

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20190228A RS58381B1 (sr) 2012-05-07 2013-05-07 Lečenje zavisnosti i poremećaja kontrole impulsa upotrebom pde7 inhibitora

Country Status (10)

Country Link
EP (1) EP2846805B1 (OSRAM)
JP (1) JP2015521177A (OSRAM)
CN (3) CN114984229A (OSRAM)
AU (1) AU2013266793B2 (OSRAM)
CA (1) CA2871151C (OSRAM)
IN (1) IN2014DN10404A (OSRAM)
PL (1) PL2846805T3 (OSRAM)
RS (1) RS58381B1 (OSRAM)
SI (1) SI2846805T1 (OSRAM)
WO (1) WO2013176877A2 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors
MX2013004943A (es) 2010-11-08 2013-09-02 Omeros Corp Tratamiento de trastornos de adicion y control de impulsos usando inhibidores de pde7.
US20190185479A1 (en) 2016-08-26 2019-06-20 Mitsubishi Tanabe Pharma Corporation Bicyclic nitrogenated heterocyclic compound
EP4541372A1 (en) * 2022-06-15 2025-04-23 Shinichi Matsumoto Drug therapy for obsessive-compulsive disorder targeting dopamine d1 signal in striatal striosomes
CA3264002A1 (en) 2022-08-18 2024-02-22 Mitodicure Gmbh USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITING ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERCISE INTOLERANCE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1775298E (pt) * 2004-07-01 2013-06-12 Daiichi Sankyo Co Ltd Derivado de tienopirazol com atividade inibidora da pde 7
US20060183763A1 (en) * 2004-12-31 2006-08-17 Pfizer Inc Novel pyrrolidyl derivatives of heteroaromatic compounds
WO2007038551A2 (en) * 2005-09-26 2007-04-05 Avigen, Inc. Use of ibudilast for treating drug and behavioral addictions
US8637528B2 (en) * 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
NZ580413A (en) * 2007-03-27 2012-11-30 Omeros Corp The use of pde7 inhibitors for the treatment of movement disorders
EP3053440B1 (en) * 2007-04-11 2020-08-12 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
FR2943673B1 (fr) * 2009-03-27 2013-03-29 Sanofi Aventis Applications therapeutiques de derives de quinazolinedione
FR2944282B1 (fr) * 2009-04-09 2013-05-03 Sanofi Aventis Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques
MX2013004943A (es) * 2010-11-08 2013-09-02 Omeros Corp Tratamiento de trastornos de adicion y control de impulsos usando inhibidores de pde7.

Also Published As

Publication number Publication date
AU2013266793A1 (en) 2014-11-27
IN2014DN10404A (OSRAM) 2015-08-14
SI2846805T1 (sl) 2019-04-30
CA2871151C (en) 2019-03-26
WO2013176877A2 (en) 2013-11-28
CN114984229A (zh) 2022-09-02
CN104768556A (zh) 2015-07-08
EP2846805B1 (en) 2018-11-21
EP2846805A4 (en) 2016-08-10
CA2871151A1 (en) 2013-11-28
PL2846805T3 (pl) 2019-05-31
EP2846805A2 (en) 2015-03-18
JP2015521177A (ja) 2015-07-27
AU2013266793B2 (en) 2016-08-04
CN112168972A (zh) 2021-01-05
WO2013176877A3 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
US20220062194A1 (en) Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
US11464785B2 (en) Treatment of addiction and impulse-control disorders using PDE7 inhibitors
EP2846805B1 (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
DK2846805T3 (en) TREATMENT OF DEPENDENCE AND IMPULSE CONTROL DISORDERS USING PDE7 INHIBITORS
US20230110784A1 (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
HK40103491A (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
HK1208373B (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors